Comments on the guidelines (2023) of the ESC on the management of cardiovascular diseases in patients with diabetes

被引：0

作者：

Marx, Nikolaus ^{[1
]}

Mueller-Wieland, Dirk ^{[1
]}

Espinola-Klein, Christine ^{[2
]}

Halle, Martin ^{[3
]}

Birkenhagen, Annette ^{[4
]}

Diemert, Patrick ^{[5
]}

Mahfoud, Felix ^{[6
,9
]}

Wienbergen, Harm ^{[7
,8
]}

Schuett, Katharina ^{[1
]}

机构：

[1] Uniklin RTWH Aachen, Med Klin Kardiol Angiol & Internist Intensivmed 1, Pauwelsstr 30, D-52074 Aachen, Germany

[2] Univ Med Mainz, Zent Kardiol, Kardiol Angiol 3, Mainz, Germany

[3] Tech Univ Munich, TUM Sch Med & Hlth, Pravent Sportmed & Sportkardiol, TUM Univ klinikum rechts Isar, Munich, Germany

[4] Kardiol Angiol Praxis, Stollberg, Germany

[5] Univ Herz & Gefasszentrum Hamburg, Klinik & Poliklin Kardiol, Hamburg, Germany

[6] Univ klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intensi, Homburg, Germany

[7] Bremer Inst Herz & Kreislaufforsch, Stiftung Bremer Herzen, Gesundheit Nord Klinikverbund Bremen, Bremen, Germany

[8] Univ Lubeck, Med Klin 2, Lubeck, Germany

[9] Deutsch Gesell Kardiol Herz & Kreislaufforsch eV D, Kommiss Klin Kardiovask Med, Dusseldorf, Germany

来源：

KARDIOLOGIE | 2024年 / 18卷 / 03期

关键词：

Diabetes mellitus; Cardiovascular disease; Heart failure; Kidney failure; EJECTION FRACTION; KIDNEY OUTCOMES; HEART-FAILURE; TYPE-2; EMPAGLIFLOZIN; METAANALYSIS; FINERENONE; MORTALITY;

D O I：

10.1007/s12181-024-00689-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with diabetes mellitus exhibit an increased risk for the development of cardiovascular diseases and the presence of both comorbidities has a major impact not only on the prognosis but also the implementation of evidence-based treatment to reduce the cardiovascular risk. The new 2023 guidelines of the European Society of Cardiology (ESC) provide firm evidence-based recommendations for the management of cardiovascular diseases in patients with diabetes. The most relevant aspects of these guidelines are summarized in the following overview article.

引用

页码：256 / 265

页数：10

共 50 条

[41] ESC Guidelines on diabetes, pre- diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary
Ryden, Lars
Grant, Peter J.
Anker, Stefan D.
Berne, Christian
Cosentino, Francesco
Danchin, Nicolas
Deaton, Christi
Escaned, Javier
Hammes, Hans-Peter
Huikuri, Heikki
Marre, Michel
Marx, Nikolaus
Mellbin, Linda
Ostergren, Jan
Patrono, Carlo
Seferovic, Petar
Sousa, Miguel
Taskinen, Marja-Riita
Tendera, Michal
Tuomilehto, Jaakko
Valensi, Paul
Luis Zamorano, Jose
Luis Zamorano, Jose
Achenbach, Stephan
Baumgartner, Helmut
Bax, Jeroen J.
Bueno, Hector
Dean, Veronica
Deaton, Christi
Erol, Cetin
Fagard, Robert
Ferrari, Roberto
Hasdai, David
Hoes, Arno W.
Kirchhof, Paulus
Knuuti, Juhani
Kolh, Philippe
Lancellotti, Patrizio
Linhart, Ales
Nihoyannopoulos, Petros
Piepoli, Massimo F.
Ponikowski, Piotr
Sirnes, Per Anton
Luis Tamargo, Juan
Tendera, Michal
Torbicki, Adam
Wijns, William
Windecker, Stephan
De Backer, Guy
Sirnes, Per Anton
DIABETES & VASCULAR DISEASE RESEARCH, 2014, 11 (03): : 133 - 173
[42] Comments on the 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease
Boraita, Araceli
Adamuz, Carmen
Alcocer Ayuga, Maria
Carro, Amelia
Diaz Gonzalez, Leonel
Ramon Heredia, Juan
Madaria, Zigor
Dolores Masia, Maria
Rossi, Miriam
Sanchez Testal, Miriam
Trias de Bes, Jordi
Azcarate, Pedro
Barriales, Roberto
Benito, Begona
Calvo-Iglesias, Francisco
Fuertes Moure, Angeles
de la Guia, Fernando
Martinez, Amparo
Martinez Alday, Jesus
Monivas, Vanessa
Peiro Molina, Esteban
Ripoll Vera, Tomas
de la Rosa, Alejandro
Avanzas, Pablo
Berga Congost, Gemma
Boraita, Araceli
Bueno, Hector
Calvo, David
Campuzano, Raquel
Delgado, Victoria
Dos, Laura
Ferreira-Gonzalez, Ignacio
Gomez Doblas, Juan Jose
Pascual Figal, Domingo
Sambola Ayala, Antonia
Viana Tejedor, Ana
Luis Ferreiro, Jose
Alfonso, Fernando
REVISTA ESPANOLA DE CARDIOLOGIA, 2021, 74 (06): : 488 - 493
[43] Comments on the Guidelines (2017) of the ESC on peripheral arterial Diseases
Espinola-Klein, C.
Dahm, J. B.
Heiss, C.
Zahn, R.
Tiefenbacher, C.
KARDIOLOGE, 2018, 12 (04): : 241 - 249
[44] New 2023 ESC Guidelines for the management of endocarditis
Flachskampf, Frank Arnold
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (22) : 1356 - 1360
[45] Comments on the European Society of Cardiology (ESC) Guidelines (2019) on "Diabetes, Prediabetes and cardiovascular Diseases" (vol 41, pg 328, 2020)
Marx, N.
Frantz, S.
Gitt, A. K.
Zirlik, A.
KARDIOLOGE, 2020, 14 (06): : 492 - 493
[46] Management of cardiomyopathies New ESC guidelines 2023
Pavo, Noemi
Hengstenberg, Christian
HERZ, 2024, 49 (01) : 22 - 32
[47] 'Ten Commandments' of the 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, Vera
EUROPEAN HEART JOURNAL, 2018, 39 (35) : 3269 - 3269
[48] What is new in the 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy?
Irene M. Lang
Wiener klinische Wochenschrift, 2020, 132 : 69 - 72
[49] What is new in the 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy?
Lang, Irene M.
WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (3-4) : 69 - 72
[50] Management von KardiomyopathienNeue ESC-Leitlinie 2023Management of cardiomyopathiesNew ESC guidelines 2023
Noemi Pavo
Christian Hengstenberg
Herz, 2024, 49 (1) : 22 - 32

← 1 2 3 4 5 →